

| 货号 | HV612086 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334) (HV612086) is a research-grade recombinant antibody targeting CD276. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 宿主 | Human |
| 同种型 | IgG-like |
| 克隆号 | Ibi-334 |
| 表达系统 | Mammalian cells |
| 克隆类型 | Monoclonal |
| 靶标 | CD276 antigen, 4Ig-B7-H3, B7 homolog 3, B7-H3, Costimulatory molecule, CD276, CD276, Epidermal growth factor receptor, EC:2.7.10.1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR |
| 内毒素水平 | < 10 EU/mg |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | Q5ZPR3 & P00533 |
| 状态 | Liquid |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | Ibi334, Ibi 334 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

SDS-PAGE for Research Grade Anti-B7-H3 & EGFR Bispecific Antibody (Ibi-334)



24小时产品查询

扫一扫关注我们

专属渠道经理